Sljedeći

Auto Play

Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman

4 Pogledi • 07/30/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play